Innovent Biologics announces the NMPA granted new indication approval for BYVASDA
BYVASDA is an anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody and a bevacizumab biosimilar independently developed by Innovent Biologics...
Dec 28